Sebaldt, R J <br/><br/>
Intermittent cyclic therapy with etidronate prevents corticosteroid-induced bone loss: two years of follow-up.  [electronic resource] 

 -  Scandinavian journal of rheumatology. Supplement  1996 
 - 91-3 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0301-3847 
<br/><br/><label>Standard No.: </label>10.3109/03009749609103760  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--adverse effects<br/>Bone Density--drug effects<br/>Cohort Studies<br/>Drug Administration Schedule<br/>Etidronic Acid--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Information Systems<br/>Male<br/>Middle Aged<br/>Osteoporosis--prevention & control<br/>Rheumatic Diseases--drug therapy<br/>Time Factors